angina pectoris/nauzea

Odkaz je uložen do schránky

Vyberte typ řazení

Strana 1 z 70 Výsledek

Ginkgo Biloba extract for angina pectoris: a systematic review.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

OBJECTIVE To evaluate the efficacy and safety of Ginkgo Biloba extract for patients with angina pectoris according to the available evidence. METHODS Electronic databases were searched for all of the randomized controlled trials (RCTs) of angina pectoris treatments with Ginkgo Biloba extract, either

[Angina pectoris -- an early sign of water intoxication during transurethral prostatectomy (author's transl)].

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Water intoxication from intravascular absorption of non-electrolyte irrigating fluid is a well-known and often serious complication of transurethral resection of the prostate. The amount of absorbed fluid depends on the duration of the operative procedure, the number of transected open venous

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

This double-blind, placebo-controlled, parallel-group, multicenter study was designed to evaluate the safety and efficacy of a new controlled-onset, extended-release formulation of verapamil hydrochloride called physiologic pattern release (PPR) verapamil. The study was conducted at 24 sites (13

Side effects of prostacyclin in patients with angina pectoris and coronary artery disease.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Although the exposure of human subjects to prostacyclin (PGI2) infusion has been broad, no systematic approaches have been made in order to investigate the dose-related side effects in patients with angina pectoris and coronary artery disease (CAD). We studied 25 patients with typical chest pain and

Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Bepridil, a new calcium-channel blocking agent with an extended plasma elimination half-life of greater than 50 hours, was compared to placebo in 77 patients with confirmed coronary artery disease and chronic stable angina pectoris. The effects of bepridil were compared with those of placebo on

An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

A multicenter, double-blind study was performed to compare the antianginal efficacy and safety of the new dihydropyridine calcium antagonist amlodipine with the benzothiazepine calcium antagonist diltiazem in patients with stable exertional angina pectoris. Following a 2-week placebo run-in period,

Treating angina pectoris by acupuncture therapy.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Acupuncture therapy on PC 6 (Neiguan) has a therapeutic effect on cardiac and chest ailments including angina pectoris. Additional beneficial acupuncture points are PC 4 (Ximen), HT 7 (Shenmen point), PC 7 (Daling point), PC 5 (Jianshi point), PC 3 (Quze point), CV 17 (Danzhong point), CV 6 (Qihai

Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Extended-release ranolazine (ranolazine ER) [Ranexa(®)] is an antianginal agent that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP). This article reviews the efficacy, safety and

Sustained effects of transdermal nitroglycerin in patients with angina pectoris.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

The antianginal efficacy of a transdermal therapeutic delivery system for nitroglycerin (TNG) was compared with that of placebo in a double-blind crossover study. Twenty-five patients with stable angina pectoris were evaluated. The transdermal system delivered 5 mg of nitroglycerin over a 24-hour

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

OBJECTIVE The anti-anginal efficacy of the selective I(f) inhibitor ivabradine has been demonstrated in controlled clinical trials. However, there is limited information about the safety and efficacy of a combined treatment of ivabradine with beta-blockers, particularly outside of clinical trials in

[Efficacy and safety of breviscapine injection in treatment of unstable angina pectoris: systematic review and Meta-analysis].

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

To systematically evaluate the efficacy and safety of breviscapine injection in the treatment of unstable angina pectoris (UAP). Eight electronic databases and clinical trials registries were searched to collect randomized controlled trials on breviscapine injection in the treatment of UAP.

Belching as a presenting symptom of angina pectoris.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Symptoms of angina pectoris can present with the typical specific symptoms, which are easy to recognize, or vague symptoms like chills, nausea, dizziness, belching and mild chest pain. Both the typical and atypical forms of angina symptoms may rarely be associated with or masked by predominantly

Atypical presentations among Medicare beneficiaries with unstable angina pectoris.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

Chest pain is a hallmark symptom in patients with unstable angina pectoris (UAP). However, little is known regarding the prevalence of an atypical presentation among these patients and its relation to subsequent care. We examined the medical records of 4,167 randomly sampled Medicare patients

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

BACKGROUND Ranolazine is a novel antianginal and anti-ischemic agent, that, unlike other available antianginal drugs in the United States (beta-blockers, organic nitrates, and calcium channel blockers), has no significant effect on either heart rate or blood pressure. Its exact mechanism of action

Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.

Články mohou překládat pouze registrovaní uživatelé

Přihlášení Registrace

BACKGROUND The antianginal efficacy of ivabradine was studied in controlled clinical trials. Strict patient selection criteria may cause a discrepancy between the results of highly controlled clinical trials and everyday routine practice. The objective of this study was to evaluate the efficacy and

Předchozí
1
2
3
4
5
další

Připojte se k naší
facebookové stránce

Herbal & Natural Medicine

Nejúplnější databáze léčivých bylin podložená vědou

Funguje v 55 jazycích
Bylinné léky podporované vědou
Rozpoznávání bylin podle obrázku
Interaktivní mapa GPS - označte byliny na místě (již brzy)
Přečtěte si vědecké publikace související s vaším hledáním
Hledejte léčivé byliny podle jejich účinků
Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty

Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu